Medulloblastoma - 38 Studies Found
| Completed |
: Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma : Recurrent Childhood Medulloblastoma : 2010-11-10 :
|
| Not yet recruiting |
: Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma : Untreated Childhood Medulloblastoma : 2016-03-25 :
|
| Completed |
: Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma : Untreated Childhood Medulloblastoma : 2013-12-13 :
|
| Completed |
: GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment : Recurrent Childhood Medulloblastoma : 2009-01-13 :
|
| Completed |
: Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma : Untreated Childhood Medulloblastoma : 2004-06-14 :
|
| Withdrawn |
: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma :
: 2012-09-28 :
|
| Recruiting |
: Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway :
|
| Recruiting |
: Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor :
: 2010-07-22 :
|
| Terminated |
: Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma :
: 2011-11-28 : Drug: TPI 287 Subjects will receive six cycles of intravenous (IV) TPI 287 at a dose of 125 mg/m2 on Day |
| Recruiting |
: Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma :
: 2008-01-14 :
|